Cornerstone Planning Group’s ResMed RMD Stock Holding History

Cornerstone Planning Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.36K	Buy	46 +18	+64%	+$4.49K	﹤0.01%	914
2025 Q4	$7.22K	Sell	28 -623	-96%	-$159K	﹤0.01%	876
2025 Q3	$2.8K	Buy	651 +622	+2,145%	+$170K	﹤0.01%	1098
2025 Q2	$8.27K	Buy	29 +7	+32%	+$1.67K	﹤0.01%	601
2025 Q1	$4.72K	Buy	22 +8	+57%	+$1.87K	﹤0.01%	749
2024 Q4	$3.57K	Buy	14 +2	+17%	+$482	﹤0.01%	654
2024 Q3	$2.93K	Buy	12 +2	+20%	+$447	﹤0.01%	690
2024 Q2	$2.16K	Buy	10 +2	+25%	+$406	﹤0.01%	751
2024 Q1	$1.74K	Hold	8	–	–	﹤0.01%	686
2023 Q4	$1.38K	Hold	8	–	–	﹤0.01%	685
2023 Q3	$1.18K	Hold	8	–	–	﹤0.01%	754
2023 Q2	$1.75K	Buy	+8	New	+$1.78K	﹤0.01%	1214
2022 Q4	$2.98K	Buy	+13	New	+$2.86K	﹤0.01%	1081

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Planning Group's RMD Position: Q1 2026 in Review

Cornerstone Planning Group increased its ResMed (RMD) stake by 64% in Q1 2026, buying an estimated $4.49K and bringing the position to 46 shares worth $9.36K. The position accounts for ﹤0.01% of the portfolio, ranked #914.

Cornerstone Planning Group first reported a position in RMD in Q4 2022 and has held it in 13 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Cornerstone Planning Group held 46 shares of ResMed worth $9.36K as of Q1 2026.
Cornerstone Planning Group bought 18 ResMed shares in Q1 2026, an estimated $4.49K.
ResMed made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q1 2026, its #914 holding.
Cornerstone Planning Group first reported a position in ResMed in Q4 2022 and has held it in 13 quarters since.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.